PAD 112 (Moexipril 15 mg)

Pill imprint PAD 112 has been identified as Moexipril hydrochloride 15 mg.

Moexipril is used in the treatment of high blood pressure; left ventricular dysfunction; heart failure; heart attack; diabetic kidney disease and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Moexipril 15 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for PAD 112 (Moexipril 15 mg)

Moexipril  hydrochloride 15 mg PAD 112
Moexipril hydrochloride
Imprint:
PAD 112
Strength:
15 mg
Color:
Beige
Size:
8.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Angiotensin converting enzyme inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Paddock Laboratories, Inc.
National Drug Code (NDC):
00574-0112
Inactive Ingredients:
lactose monohydrate
crospovidone
magnesium oxide
povidone
silicon dioxide
magnesium stearate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54569-5916 A S Medication Solutions LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Questions about Atrial Fibrillation? Get answers from our expert. Watch Video

Close
Hide
(web3)